Zoobiquity Colorado: Connecting human and animal health through regenerative medicine is a two-day conference that will take place at the University of Colorado Anschutz Medical Campus and Colorado State University Oct. 5 and 6. This national meeting, focusing on regenerative medicine advances, is built on a One Health concept designed to bring together leading clinicians and scientists in human and veterinary medicine.
Zoobiquity Colorado will highlight the laboratory and clinical research of human and veterinary investigators and foster ongoing and future collaborations. Researchers at CSU and CU Anschutz have collaborations that include clinical trials at CSU's James L. Voss Veterinary Teaching Hospital, and multiple studies in the CU Cancer Center and the Gates Center for Regenerative Medicine that involve natural animal models.
The program will consist of a half-day field trip to Fort Collins and tours of CSU research laboratories, followed by a full day of case presentations and panel discussions on the Anschutz Medical Campus in Denver. Busing between campuses and meals will be provided. Find more information on the Zoobiquity Colorado conference site.
Topics to be covered include: regenerative medicine approaches to cancer, wound healing, orthopedics, and ophthalmology; the regulatory environment in human and animal research; and perspectives from the U.S. Food and Drug Administration.
Coined by Dr. Barbara Natterson-Horowitz and Kathryn Bowers in their 2012 book, "Zoobiquity: The Astonishing Connection Between Human and Animal Health," zoobiquity comes from the Greek for "animal," zo, and the Latin for "everywhere," ubique.
Animals and humans share the planet, and they have many illnesses in common: cancer, arthritis, organ failure, injuries, and toxicities. In the past, the art and science of medicine was practiced across species because human and domestic animals were so co-dependent. But as humans have lived farther from their livestock and food-source wildlife, a gulf has opened between veterinary medicine and human medicine.
Zoobiquity seeks to bridge that gulf. Founded in 2011, Zoobiquity Conferences are designed to bring together leading clinicians and scientists in human and veterinary medicine to discuss the same diseases in a wide spectrum of animal species and human beings. The intention of this cross-disciplinary conference is to create conversations and relationships between human and veterinary colleagues confronted with similar clinical challenges. By crossing disciplines in this way, we can significantly expand the perspective of clinicians, scientists and patients about these shared disorders and broader health concerns.
In the case of regenerative medicine, this cutting-edge field is already familiar to veterinarians. The regulatory constraints prohibiting the use of certain stem cell therapies in humans have not hindered veterinary researchers, who have been using these therapies for two decades in equine patients. These treatments have been reimbursed by equine health insurance companies, as their effectiveness has been demonstrated and measured in horses.